Pharma

Pharmalot Ed Silverman

Will the European Union give vouchers to pharma to develop badly needed antibiotics?

Pharmalot Ed Silverman

Pharmalittle: India regulator finds 5% of drug samples are substandard; EMA claims new clinical trial registry is fixed

Pharmalot Ed Silverman

Pharmalittle: HIV vaccine study is stopped early; Merck has a plan to combat carcinogen found in diabetes drugs

Health Elaine Chen

Mix-it-yourself Wegovy? Some are trying risky sources for weight-loss drugs

Pharmalot Ed Silverman

Major purchasers predict expensive new therapies will keep driving drug price hikes

Pharmalot Ed Silverman

Pfizer says it will widen access to hundreds of off-patent medicines in low-income countries

Pharmalot Ed Silverman

Pharmalittle: Lilly and AbbVie exit U.K. drug-pricing program; J&J scales back Covid-19 vaccine production

Pharmalot Ed Silverman

Large health insurers lowered barriers to fair access to some drugs, analysis finds

First Opinion Daniel Eisenkraft Klein

Stop blaming Biogen for putting profit at the expense of patients. Blame the systems that enabled it

Pharmalot Ed Silverman

Up and down the ladder: The latest comings and goings

Pharmalot Ed Silverman

Pharmalittle: Pharma prioritizes biologics over pills due to drug-pricing law; former Takeda employee accused of creating fake consulting firm

Pharmalot Ed Silverman

California is the latest state to sue drugmakers and PBMs over insulin pricing

Biotech Jonathan Saltzman — Boston Globe

‘We become millionaires and we retire babe’: Former Takeda worker and boyfriend accused of $2.3 million scam of drug firm

Pharmalot Ed Silverman

Pharmalittle: HHS readying details for Medicare drug-price negotiations; doctors urge FDA to hold expert meeting before approving Alzheimer’s drug

First Opinion Vanessa Almendro

Democratizing drug development will be a win for all

Pharmalot Ed Silverman

Physicians group urges FDA to convene expert panel before finally approving an Alzheimer’s drug

Pharmalot Ed Silverman

Pharmalittle: Pfizer will not license generic Covid-19 pill in China; BioMarin signs outcomes-based deal in Germany for gene therapy

Pharmalot Ed Silverman

Lawmakers again urge the Biden administration to use federal law to widen access to a cancer drug

Pharmalot Ed Silverman

FDA scolds Sun Pharmaceutical for serious quality control problems at a key plant in India

Pharmalot Ed Silverman

Pharmalittle: FDA increasingly pausing trials of experimental meds; FDA commish isn’t surprised by congressional report on Alzheimer’s drug

Pharma Kate Sheridan

People hate drug ads on TV. Here’s the 4 issues they complain about most

Pharmalot Ed Silverman

Moderna plans to follow in Pfizer’s footsteps, charge up to $130 for Covid-19 vaccine in U.S.

Biotech Matthew Herper

Novavax replaces CEO, citing need for ‘fresh perspective’

Biotech Jonathan Wosen and Allison DeAngelis

A flurry of pharma acquisitions kick off JPM week after a slow year for deals

Pharmalot Ed Silverman

Pharmalittle: Pediatricians recommend obesity drugs for children; as JPM starts, industry execs have a gloomy financing outlook

Pharma Patrick Skerrett

India’s lax oversight of pharmaceutical manufacturing imperils health around the world

Pharmalot Ed Silverman

The FDA has approved a new Alzheimer’s drug, but wide access may depend on CMS easing restrictions

Biotech Adam Feuerstein

FDA approves Alzheimer’s drug shown to moderately slow cognitive decline in early stages of the disease

Pharmalot Ed Silverman

Up and down the ladder: The latest comings and goings